Poor Sensitivity of Symptoms in Early Detection of COPD

Figures & data

Table 1 Baseline disease of subjects

	Number (%)
Total	288
Chronic hepatitis	97 (33.7)
Fatty liver/Hyperlipidemia	79 (26.4)
Liver cirrhosis	24 (8.3)
Hepatocellular carcinoma	24 (8.3)
Autoimmune hepatitis	13 (4.5)
Diabetes	10 (3.5)
Hypertension	9 (3.1)
Alcoholic hepatitis	8 (2.8)
Others	27 (9.4)

Table 2 Characteristics of subjects

	All subjects	FEV1/FVC < 0.70
Total	288	44 (15.3)
Age (years)
40–49	31	0 (0.0)
50–59	74	6 (8.1)
60–69	105	16 (15.2)
70–	78	22 (28.2)
Gender
Female	128	18 (14.1)
Male	160	26 (16.3)
Smoking status
Never	151	15 (9.9)
Ex	69	14 (20.3)
Current	68	15 (22.1)
Smoking amount (pack-years)
0–24	43	6 (14.0)
25–49	56	10 (17.9)
50–	38	13 (34.2)

*% of all subjects.

Figure 1 Study flow diagram. The number in each panel indicate the number of patients.

Figure 2 Smoking status and symptoms of subjects with COPD. Left panel indicates smoking status of 25 patients who had diagnosed COPD (A). Right panel indicates symptoms of patients who had diagnosed COPD (B). The number in each panel indicate the patient number.